AAIM
REGN icon

American Assets Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

American Assets Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.32M Hold
3,000
– – 0.16% 114
2025
Q4 		$2.32M Hold
3,000
– – 0.16% 113
2025
Q3 		$1.69M Hold
3,000
– – 0.12% 119
2025
Q2 		$1.57M Hold
3,000
– – 0.13% 120
2025
Q1 		$1.9M Buy
+3,000
New +$2.06M 0.17% 118

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

American Assets Investment Management's REGN Position: Q1 2026 in Review

American Assets Investment Management held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2026 at 3,000 shares worth $2.32M. The position accounts for 0.16% of the portfolio, ranked #114.

American Assets Investment Management first reported a position in REGN in Q1 2025 and has held it in 5 quarters since. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • American Assets Investment Management held 3,000 shares of Regeneron Pharmaceuticals worth $2.32M as of Q1 2026.
  • American Assets Investment Management left its Regeneron Pharmaceuticals share count unchanged in Q1 2026.
  • Regeneron Pharmaceuticals made up 0.16% of American Assets Investment Management's portfolio in Q1 2026, its #114 holding.
  • American Assets Investment Management first reported a position in Regeneron Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • 1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on American Assets Investment Management's 13F filing for Q1 2026, filed 11 May 2026.